377 related articles for article (PubMed ID: 20162690)
21. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
22. Colloidal polymeric nanoparticles and brain drug delivery.
Khalil NM; Mainardes RM
Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
[TBL] [Abstract][Full Text] [Related]
23. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
Cramer S; Rempe R; Galla HJ
Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
[TBL] [Abstract][Full Text] [Related]
24. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
25. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
26. siRNA as a tool to improve the treatment of brain diseases: Mechanism, targets and delivery.
Gomes MJ; Martins S; Sarmento B
Ageing Res Rev; 2015 May; 21():43-54. PubMed ID: 25796492
[TBL] [Abstract][Full Text] [Related]
27. Solid lipid nanoparticles for targeted brain drug delivery.
Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
[TBL] [Abstract][Full Text] [Related]
28. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
Rempe R; Cramer S; Qiao R; Galla HJ
Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
[TBL] [Abstract][Full Text] [Related]
29. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
[TBL] [Abstract][Full Text] [Related]
30. Potential of solid lipid nanoparticles in brain targeting.
Kaur IP; Bhandari R; Bhandari S; Kakkar V
J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticulate systems for drug delivery and targeting to the central nervous system.
Craparo EF; Bondì ML; Pitarresi G; Cavallaro G
CNS Neurosci Ther; 2011 Dec; 17(6):670-7. PubMed ID: 20950327
[TBL] [Abstract][Full Text] [Related]
32. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
Guarnieri D; Muscetti O; Netti PA
Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
[TBL] [Abstract][Full Text] [Related]
33. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
34. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
36. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
Tosi G; Costantino L; Rivasi F; Ruozi B; Leo E; Vergoni AV; Tacchi R; Bertolini A; Vandelli MA; Forni F
J Control Release; 2007 Sep; 122(1):1-9. PubMed ID: 17651855
[TBL] [Abstract][Full Text] [Related]
37. Lipid Nanoparticles: A Novel Approach for Brain Targeting.
Shankar R; Joshi M; Pathak K
Pharm Nanotechnol; 2018; 6(2):81-93. PubMed ID: 29886842
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
[TBL] [Abstract][Full Text] [Related]
39. Hazard effects of nanoparticles in central nervous system: Searching for biocompatible nanomaterials for drug delivery.
Leite PE; Pereira MR; Granjeiro JM
Toxicol In Vitro; 2015 Oct; 29(7):1653-60. PubMed ID: 26116398
[TBL] [Abstract][Full Text] [Related]
40. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
Garg T; Bhandari S; Rath G; Goyal AK
J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
